PTC Therapeutics
PTCT
#3103
Rank
NZ$8.95 B
Marketcap
NZ$107.28
Share price
0.79%
Change (1 day)
-7.88%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: NZ$8.95 Billion

As of October 2026 PTC Therapeutics has a market cap of NZ$8.95 Billion. This makes PTC Therapeutics the world's 3103th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$8.95 B-17.79%
2025NZ$10.89 B76.08%
2024NZ$6.18 B88.08%
2023NZ$3.28 B-25.04%
2022NZ$4.38 B6.42%
2021NZ$4.12 B-28.57%
2020NZ$5.77 B30.67%
2019NZ$4.41 B70.59%
2018NZ$2.58 B165.72%
2017NZ$0.97 B80.28%
2016NZ$0.54 B-66.34%
2015NZ$1.60 B-26.14%
2014NZ$2.17 B342.21%
2013NZ$0.49 B

End of Day market cap according to different sources

On Oct 26th, 2026 the market cap of PTC Therapeutics was reported to be:

NZ$8.95 Billion
by Nasdaq info icon info icon
NZ$8.95 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$513.56 B 5,635.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$230.26 B 2,471.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$3.81 B-57.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.33 B-62.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.43 B-95.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$19.76 B 120.70%๐Ÿ‡บ๐Ÿ‡ธ USA